Insulinoma overview: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{CMG}} {{Insulinoma}} ==Overview== An '''insulinoma''' is a tumour of the pancreas derived from the beta cells which while retaining the ability to synthesize an...")
 
No edit summary
Line 4: Line 4:
==Overview==
==Overview==
An '''insulinoma''' is a [[tumour]] of the [[pancreas]] derived from the [[beta cell]]s which while retaining the ability to synthesize and secrete [[insulin]] is autonomous of the normal feedback mechanisms. Patients present with symptomatic [[hypoglycemia]] which is ameliorated by feeding. The diagnosis of an insulinoma is usually made biochemically with low blood sugar, elevated insulin, pro-insulin and C-peptide levels and confirmed by [[medical imaging]] or angiography. The definitive treatment is surgery.
An '''insulinoma''' is a [[tumour]] of the [[pancreas]] derived from the [[beta cell]]s which while retaining the ability to synthesize and secrete [[insulin]] is autonomous of the normal feedback mechanisms. Patients present with symptomatic [[hypoglycemia]] which is ameliorated by feeding. The diagnosis of an insulinoma is usually made biochemically with low blood sugar, elevated insulin, pro-insulin and C-peptide levels and confirmed by [[medical imaging]] or angiography. The definitive treatment is surgery.
==Historical Perspective==
==Pathogenesis==
==Causes==
==Differential Diagnosis==
==Epidemiology and Demographics==
==Risk Factors==
==Screening==
==Natural History, Complications and Prognosis==
==Staging==
==History and Symptoms==
==Physical Examination==
==Laboratory Findings==
==CT==
==MRI==
==Ultrasonography==
==Other Imaging Findings==
==Other Diagnostic Findings==
==Medical Therapy==
==Surgery==
==Primary Prevention==
==Secondary Prevention==


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 21:45, 7 October 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Insulinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Insulinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Insulinoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Insulinoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Insulinoma overview

CDC on Insulinoma overview

Insulinoma overview in the news

Blogs on Insulinoma overview

Directions to Hospitals Treating Insulinoma

Risk calculators and risk factors for Insulinoma overview

Overview

An insulinoma is a tumour of the pancreas derived from the beta cells which while retaining the ability to synthesize and secrete insulin is autonomous of the normal feedback mechanisms. Patients present with symptomatic hypoglycemia which is ameliorated by feeding. The diagnosis of an insulinoma is usually made biochemically with low blood sugar, elevated insulin, pro-insulin and C-peptide levels and confirmed by medical imaging or angiography. The definitive treatment is surgery.

Historical Perspective

Pathogenesis

Causes

Differential Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasonography

Other Imaging Findings

Other Diagnostic Findings

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References